fibrinogen has been researched along with Acute Promyelocytic Leukemia in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.43) | 18.7374 |
| 1990's | 8 (22.86) | 18.2507 |
| 2000's | 6 (17.14) | 29.6817 |
| 2010's | 14 (40.00) | 24.3611 |
| 2020's | 3 (8.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, S; Shi, J; Wang, C; Wang, Y; Zuo, N | 1 |
| Li, R; Shang, H; Zhao, L | 1 |
| Arcese, W; Breccia, M; Cicconi, L; De Bellis, E; Del Principe, MI; Di Giuliano, F; Divona, M; Garaci, F; Gurnari, C; Lo-Coco, F; Piciocchi, A; Scalzulli, E; Venditti, A; Voso, MT | 1 |
| Dai, K; Li, Y; Wu, L; Yu, K; Zhang, Q; Zhang, S | 1 |
| Bai, Y; Chen, Y; Duan, L; Huo, L; Mi, R; Shi, M; Sun, K; Wang, C; Waqas Ahmed, HA; Wei, X; Wu, D; Xu, F; Yang, R; Yang, X; Zhang, W | 1 |
| Dalton, WB; DeZern, AE; Ghiaur, G; Gladstone, DE; Gojo, I; Gondek, LP; Hambley, BC; Jasem, J; Levis, MJ; Norsworthy, KJ; Pratz, KW; Prince, G; Shenderov, E; Showel, MM; Smith, BD; Streiff, MB; Webster, JA; Zimmerman, JW | 1 |
| Brown, V; Chazot, PL; Comer, D; Dib, K; Ennis, M; Jenei, V; Katebe, M; McFarlane, C; Perecko, T; Scheithauer, T; Thurmond, RL | 1 |
| Han, JY; Kim, DH; Kim, HJ; Kim, SH; Kim, SY; Koh, MS; Lee, HJ; Lee, JH; Lee, S; Oh, SY | 1 |
| Li, D; Luo, D; Wu, S; Zhang, Y; Zhou, J | 1 |
| Jin, J; Lou, Y; Mai, W; Meng, H; Qian, W; Suo, S; Tong, H; Wei, J; Yu, W | 1 |
| Dolan, M; Ngaruiya, C | 1 |
| Al Mohareb, F; Al Qurashi, F; Al Shanqeeti, A; Al Sharif, F; Al Zahrani, H; Aljurf, M; Chaudhri, N; Iqbal, A; Nurgat, ZA; Owaidah, T; Sahovic, E; Sanz, M; Zaidi, SZ | 1 |
| Iversen, PO; Sioud, M; Sørensen, DR | 1 |
| Choi, Y; Jeon, M; Kang, YA; Kim, DY; Kim, JY; Kim, SD; Lee, JH; Lee, KH; Lee, YJ; Lee, YS; Lim, SN; Seol, M | 1 |
| Amrein, P; Attar, E; Ballen, K; Deangelo, D; Fox, E; Neuberg, D; Singh, H; Stone, R; Wadleigh, M; Werner, L | 1 |
| Chang, H; Dunn, P; Hung, YS; Kuo, MC; Lin, TL; Shih, LY; Tang, TC; Wang, PN; Wu, JH | 1 |
| Choudhry, A; DeLoughery, TG | 1 |
| DIDISHEIM, P; MIBASHAN, RS; TROMBOLD, JS; VANDERVOORT, LE | 1 |
| Hirota-Kawadobora, M; Kobayashi, H; Okumura, N; Saito, H; Terasawa, F; Tozuka, M | 1 |
| Brenner, B; Dally, N; Haddad, N; Hoffman, R; Rowe, JM; Sarig, G | 1 |
| Castaigne, S; Chomienne, C; Daniel, MT; Degos, L; Dombret, H; Fenaux, P; Micléa, JM; Scrobohaci, ML | 1 |
| Fujimoto, T; Fujimura, K; Kuramoto, A; Noda, M; Shimomura, T; Takafuta, T | 1 |
| Hvidman, LE; Nielsen, JL; Stentoft, J | 1 |
| Binder, BR; Kohno, I; Okabe, H; Okajima, K; Soe, G; Takatsuki, K | 1 |
| Castaigne, S; Daniel, MT; Degos, L; Dombret, H; Ghorra, P; Scrobohaci, ML; Zini, JM | 1 |
| al-Bitar, M; Estey, EH; Kantarjian, HM; Keating, M; O'Brien, S; Pierce, S; Pollicardo, N | 1 |
| Alfaro, E; Cygler, AM; Delfino, S; Felice, MS; Rose, AB; Sackmann-Muriel, F; Zubizarreta, PA | 1 |
| Avvisati, G; Castaman, G; De Sanctis, V; Di Bona, E; Luce Vegna, M; Mandelli, F; Rodeghiero, F | 1 |
| Gabazza, EC; Kageyama, S; Kato, H; Kumeda, K; Masuya, M; Mori, Y; Nakasaki, T; Nishikawa, M; Okugawa, Y; Shiku, H; Wada, H; Watanabe, R | 1 |
| Bos, R; Fijnheer, R; Nieuwenhuis, HK; Oudijk, EJ | 1 |
| Alfaro, J; Chuecas, F; Grebe, G; Lira, P; Loredo, E; Muñoz, B | 1 |
| Scharf, RE; Schneider, W; Stoffels, U | 1 |
| Williams, EC | 1 |
| Dixon, DO; Hester, JP; Keating, MJ; Khorana, S; Ventura, GJ | 1 |
| Adachi, M; Kondo, S; Nobusawa, A; Ryo, R; Saigo, K; Sugano, W; Yamaguchi, N; Yasunaga, M; Yoneda, N; Yoshida, A | 1 |
1 review(s) available for fibrinogen and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Bleeding and thrombosis in acute promyelocytic leukemia.
Topics: Antifibrinolytic Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation Tests; Clinical Trials as Topic; Combined Modality Therapy; Cysteine Endopeptidases; Disseminated Intravascular Coagulation; Factor VIIa; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Plasma; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thromboplastin; Thrombosis; Treatment Failure; Tretinoin | 2012 |
3 trial(s) available for fibrinogen and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Topics: Adult; Aged; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors | 2019 |
High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pilot Projects; Remission Induction; Tretinoin; Young Adult | 2010 |
Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytogenetics; Dexamethasone; Disease-Free Survival; Disseminated Intravascular Coagulation; Drug Administration Schedule; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Leukemia, Promyelocytic, Acute; Male; Platelet Count; Retrospective Studies; Risk Factors; Survival; Time Factors; Tretinoin | 2000 |
31 other study(ies) available for fibrinogen and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition.
Topics: Animals; Estrone; Fibrin; Fibrinogen; Hemorrhage; Leukemia, Promyelocytic, Acute; Mice | 2022 |
Acute Promyelocytic Leukemia Suggesting a Diagnosis of Myelodysplastic Syndrome: a Diagnostic Dilemma.
Topics: Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Peroxidase | 2022 |
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Female; Fibrinogen; Humans; Hydrocephalus; International Normalized Ratio; Intracranial Hemorrhages; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mortality; Neuroradiography; Precision Medicine; Predictive Value of Tests; Remission Induction; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2021 |
Plasma fibrinogen levels correlate with prognosis and treatment outcome in patients with non-M3 acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Cytogenetic Analysis; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Prognosis; ROC Curve; Young Adult | 2019 |
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Thrombosis; Young Adult | 2019 |
The histamine H4 receptor is a potent inhibitor of adhesion-dependent degranulation in human neutrophils.
Topics: Cell Adhesion; Cell Degranulation; Cell Line, Tumor; Cell Shape; Cells, Cultured; Cytochalasin B; Fibrinogen; Histamine; Humans; Indoles; Leukemia, Promyelocytic, Acute; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; MAP Kinase Signaling System; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oximes; p38 Mitogen-Activated Protein Kinases; Piperazines; Piperidines; Protein Conformation; Pyridines; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; RNA, Messenger | 2014 |
Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Topics: Adult; Aged; Biomarkers; Chi-Square Distribution; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Logistic Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Young Adult | 2015 |
Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
Topics: Adolescent; Adult; Aged; Arsenic Trioxide; Arsenicals; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Platelet Count; Prothrombin Time; Retrospective Studies; Tretinoin; Young Adult | 2016 |
Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Blood Coagulation; Case-Control Studies; Early Diagnosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Young Adult | 2016 |
Acute Promyelocytic Leukemia Presenting as Focal Neurologic Findings and Deteriorating Mental Status.
Topics: Blood Platelets; Consciousness; Emergency Service, Hospital; Factor VIII; Fibrinogen; Humans; Intracranial Hemorrhages; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nervous System Diseases; Thrombocytopenia; Tomography, X-Ray Computed; Tretinoin | 2017 |
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia.
Topics: Animals; Antithrombin III; Biomarkers; Blood Coagulation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Therapy; Interleukin-10; Leukemia, Promyelocytic, Acute; Male; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred BN; RNA Interference; RNA, Small Interfering; Thrombophilia; Thromboplastin; Transfection | 2010 |
Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Tretinoin; Young Adult | 2011 |
Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations.
Topics: Adult; Disease-Free Survival; Female; Fibrinogen; fms-Like Tyrosine Kinase 3; Humans; Inverted Repeat Sequences; Leukemia, Promyelocytic, Acute; Male; Mutation; Risk; Survival Rate; Treatment Outcome; Young Adult | 2010 |
Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Databases, Factual; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Prothrombin Time; Risk | 2012 |
ACUTE PROMYELOCYTIC LEUKEMIA WITH FIBRINOGEN AND FACTOR V DEFICIENCIES.
Topics: Afibrinogenemia; Blood Cell Count; Bone Marrow Examination; Drug Therapy; Factor V Deficiency; Fibrinogen; Humans; Hypoprothrombinemias; Leukemia; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Mercaptopurine; Pathology; Statistics as Topic; Thrombocytopenia | 1964 |
The Aalpha-chain 6Ile/Val polymorphism is not associated with plasma fibrinogen levels in Japanese.
Topics: Adult; Amino Acid Substitution; Base Sequence; DNA Primers; Female; Fibrinogen; Humans; Isoleucine; Leukemia, Promyelocytic, Acute; Mutation, Missense; Polymorphism, Genetic; Valine | 2003 |
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis | 2005 |
In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinolysin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prospective Studies; Thrombin; Tretinoin | 1995 |
50-kD integrin-associated protein does not detectably influence several functions of glycoprotein IIb-IIIa complex in human platelets.
Topics: Animals; Antigens, CD; Blood Platelets; Calcium; Carrier Proteins; CD47 Antigen; Cell Adhesion; CHO Cells; Cricetinae; Cricetulus; Erythrocytes; Fibrinogen; Humans; Integrin beta3; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Neutrophils; Platelet Aggregation; Platelet Membrane Glycoproteins; Recombinant Fusion Proteins; Thrombasthenia; Transfection; Tumor Cells, Cultured | 1995 |
All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
Topics: Adult; Female; Fibrinogen; Hemoglobins; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Platelet Count; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Third; Remission Induction; Thrombin Time; Tretinoin | 1994 |
Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency.
Topics: Adult; Aged; alpha-2-Antiplasmin; Aortic Aneurysm, Abdominal; Chromatography, Affinity; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoblotting; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prostatic Neoplasms; Stomach Neoplasms | 1994 |
Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Topics: Adolescent; Cell Differentiation; Child; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prospective Studies; Thrombin; Time Factors; Tretinoin | 1993 |
Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Prognosis; Remission Induction; Survival Rate | 1996 |
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Incidence; Infant; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Morbidity; Multivariate Analysis; Platelet Count; Prospective Studies; Remission Induction; Time Factors; Tretinoin | 2000 |
Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
Topics: Adolescent; Adult; Antigens; Female; Fibrinogen; Hemostasis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Thromboplastin; Tissue Plasminogen Activator | 2000 |
Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Blood Coagulation Tests; Disease Susceptibility; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Pancreatic Elastase; Sepsis | 2000 |
[Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
Topics: Adolescent; Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Thrombocytopenia | 1991 |
Thrombin generation in acute myeloblastic leukemia.
Topics: Fibrinogen; Fibrinopeptide A; Hemorrhagic Disorders; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukocyte Count; Neoplastic Stem Cells; Thrombin | 1990 |
Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Topics: Adolescent; alpha-2-Antiplasmin; Aminocaproic Acid; Blood Coagulation Disorders; Child; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Liver Diseases; Male; Neoplasm Metastasis | 1989 |
Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Platelet Count; Platelet Transfusion; Remission Induction; Retrospective Studies; Risk Factors | 1989 |
[Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Factor XIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute | 1989 |